Mycobacterium tuberculosis MmpL3

Bryan Berube1,2, Aditi Deshpande1, Amala Bhagwat1

  • 1Center for Global Infectious Disease, Seattle Children's Research Institute, Seattle, WA, USA.

概括

新型抗结核药物NITD-349显示了低密度Mycobacterium结核菌培养物的快速杀死. 将NITD-349与异化结合使用可以防止耐药性,即使在高细菌负载下也是如此.